JPH11500728A - バンド付き持続放出活性剤投与形 - Google Patents
バンド付き持続放出活性剤投与形Info
- Publication number
- JPH11500728A JPH11500728A JP8525724A JP52572496A JPH11500728A JP H11500728 A JPH11500728 A JP H11500728A JP 8525724 A JP8525724 A JP 8525724A JP 52572496 A JP52572496 A JP 52572496A JP H11500728 A JPH11500728 A JP H11500728A
- Authority
- JP
- Japan
- Prior art keywords
- active agent
- matrix
- dosage form
- fluid
- agent formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.流体の使用環境に活性剤製剤を持続投与するための活性剤投与形であっ て、活性剤製剤マトリックスと、該活性剤製剤マトリックスの表面上に間隔を置 いた関係で配置された少なくとも2個の不溶性バンドとを含み、各バンドの両側 のマトリックスの表面が流体の使用環境に暴露される投与形。 2.バンドが活性剤製剤マトリックスの表面上に配置される、請求項1記載 の投与形。 3.マトリックスが侵食されるにつれて、バンドが落下する、請求項2記載 の投与形。 4.活性剤製剤マトリックスの表面上にバンドがプリントされる、請求項1 記載の投与形。 5.活性剤製剤が薬物を含む、請求項1記載の活性剤投与形。 6.活性剤製剤が薬物を含み、投与形が経口投与される、請求項1記載の活 性剤投与形。 7.活性剤製剤マトリックスが活性剤製剤と親水性ポリマー物質とを含む、 請求項1記載の活性剤投与形。 8.投与形が円筒形であり、不溶性バンドが活性剤製剤マトリックスを同心 的に囲む、請求項1記載の投与形。 9.流体の使用環境に活性剤製剤を持続投与するための活性剤投与形であっ て、第1活性剤製剤マトリックスと、第1活性剤製剤マトリックスの表面上に間 隔を置いた関係で配置された少なくとも2個の不溶性バンドと、流体の使用環境 に暴露される、各バンドの両側の第1活性剤製剤マトリックスの表面と、第2活 性剤製剤マトリックスとを含み、第1活性剤製剤マトリックスが第1活性剤の持 続投与を可能にし、第2活性剤製剤マトリックスが第2活性剤の初期パルスを与 え、第2活性剤が第1活性剤と同一であるか又は第1活性剤とは異なるものであ る投与形。 10.活性剤製剤の投与が約20時間まで続く、請求項1記載の活性剤投与 形。 11.不溶性バンドが約0.5〜8mmの幅である、請求項1記載の活性剤 投与形。 12.不溶性バンドの総数が2〜10個である、請求項1記載の活性剤投与 形。 13.流体の使用環境に活性剤製剤を持続放出するための活性剤投与形の製 造方法であって、 (a)活性剤製剤マトリックスを製造する工程と、 (b)不溶性物質を活性剤製剤マトリックス上に施用して、活性剤製剤マトリ ックスの表面上に少なくとも2個の不溶性バンドを形成する工程と を含む方法。 14.工程(b)において、不溶性物質の施用が活性剤製剤マトリックス上 に不溶性物質をプリントすることによっておこなわれる、請求項13記載の方法 。 15.流体の使用環境に活性剤を長時間にわたって投与する方法であって、 (a)その表面上に間隔を置いた関係で配置された少なくとも2個の不溶性バ ンドを有する活性剤製剤マトリックスを流体の使用環境に配置し、各バンドの両 側の活性剤製剤マトリックスの表面を流体の使用環境に暴露させる段階と; (b)マトリックスが流体の使用環境において侵食される段階と; (c)バンドがマトリックスから落下して、マトリックスの表面が流体の使用 環境に暴露される段階と を含む方法。 16.流体の使用環境に活性剤を長時間にわたって投与する方法であって、 (a)その表面上に間隔を置いた関係で配置された少なくとも2個の不溶性バ ンドを有する活性剤製剤マトリックスを流体の使用環境に配置し、各バンドの両 側の活性剤製剤マトリックスの表面を流体の使用環境に暴露させる段階と; (b)バンドが活性剤製剤マトリックスの表面上に配置された状態で留まると きに、マトリックスが流体の使用環境において侵食される段階と、 を含み、バンドによって覆われないマトリックスの表面積が時間が経つにつれて 増大する方法。 17.流体の使用環境に第1活性剤と第2活性剤とを投与する方法であって 、 (a)第1活性剤を含み、その表面上に間隔を置いた関係で配置された少なく とも2個の不溶性バンドを有する第1活性剤製剤マトリックスを流体の使用環境 に配置し、各バンドの両側の活性剤製剤マトリックスの表面を流体の使用環境に 暴露させる段階と; (b)第2活性剤を含む第2活性剤製剤マトリックスを流体の使用環境中に配 置する段階と; (c)第1活性剤製剤マトリックスが流体の使用環境において侵食されて、前 記第1活性剤が持続投与される段階と; (d)第2活性剤マトリックスが流体の使用環境において侵食されて、第2活 性剤の初期パルスを与える段階と を含み、第1活性剤と第2活性剤とが同じものであっても異なるものであっても よい方法。 18.マトリックスが流体の使用環境において侵食されるにつれて、バンド が第1活性剤製剤マトリックスの表面から落下する、請求項17記載の方法。 19.マトリックスが流体の使用環境において侵食されても、バンドが第1 活性剤製剤マトリックスの表面に配置された状態で留まる、請求項17記載の方 法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/394,074 US5534263A (en) | 1995-02-24 | 1995-02-24 | Active agent dosage form comprising a matrix and at least two insoluble bands |
US08/394,074 | 1995-02-24 | ||
PCT/US1996/001848 WO1996025922A2 (en) | 1995-02-24 | 1996-02-09 | Banded prolonged release active agent dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11500728A true JPH11500728A (ja) | 1999-01-19 |
JP3955320B2 JP3955320B2 (ja) | 2007-08-08 |
Family
ID=23557446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52572496A Expired - Fee Related JP3955320B2 (ja) | 1995-02-24 | 1996-02-09 | バンド付き持続放出活性剤投与形 |
Country Status (17)
Country | Link |
---|---|
US (4) | US5534263A (ja) |
EP (1) | EP0810856B1 (ja) |
JP (1) | JP3955320B2 (ja) |
KR (1) | KR100465268B1 (ja) |
CN (1) | CN1142771C (ja) |
AT (1) | ATE200421T1 (ja) |
AU (1) | AU703681B2 (ja) |
DE (1) | DE69612481T2 (ja) |
DK (1) | DK0810856T3 (ja) |
ES (1) | ES2155931T3 (ja) |
FI (1) | FI973452A0 (ja) |
GR (1) | GR3035743T3 (ja) |
HK (1) | HK1005794A1 (ja) |
NO (1) | NO319216B1 (ja) |
NZ (1) | NZ303809A (ja) |
PT (1) | PT810856E (ja) |
WO (1) | WO1996025922A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001519379A (ja) * | 1997-10-09 | 2001-10-23 | ペリオ、プロダクツ、リミテッド | 遅延性総放出胃腸薬物送達システム |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
SE9603667D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | Pharmaceutical compositions |
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
DK0989848T3 (da) * | 1997-06-11 | 2005-01-17 | Procter & Gamble | Filmovertrukken tablet til forbedret sikkerhed i øvre mave-tarm-kanal |
ES2234139T3 (es) * | 1997-08-11 | 2005-06-16 | Alza Corporation | Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica. |
IN186245B (ja) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
US6365183B1 (en) * | 1998-05-07 | 2002-04-02 | Alza Corporation | Method of fabricating a banded prolonged release active agent dosage form |
EP1413296A1 (en) * | 1998-05-07 | 2004-04-28 | ALZA Corporation | Method of fabricating a banded prolonged release active agent dosage form |
US6099862A (en) | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
HU230454B1 (hu) | 1998-11-02 | 2016-07-28 | Alkermes Pharma Ireland Limited | Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény |
US20090297597A1 (en) * | 1998-11-02 | 2009-12-03 | Gary Liversidge | Modified Release Ticlopidine Compositions |
US20090149479A1 (en) * | 1998-11-02 | 2009-06-11 | Elan Pharma International Limited | Dosing regimen |
US20060240105A1 (en) * | 1998-11-02 | 2006-10-26 | Elan Corporation, Plc | Multiparticulate modified release composition |
US20070122481A1 (en) * | 1998-11-02 | 2007-05-31 | Elan Corporation Plc | Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer |
US6797283B1 (en) | 1998-12-23 | 2004-09-28 | Alza Corporation | Gastric retention dosage form having multiple layers |
US6342249B1 (en) | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
US6635281B2 (en) | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
WO2000038650A1 (en) * | 1998-12-23 | 2000-07-06 | Alza Corporation | Gastric retention dosage form having multiple layers |
US6498153B1 (en) | 1998-12-31 | 2002-12-24 | Akzo Nobel N.V. | Extended release growth promoting two component composition |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
CN1407884B (zh) | 1999-10-29 | 2012-06-20 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
DE10003757A1 (de) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
US7056531B1 (en) | 2000-05-04 | 2006-06-06 | Nature's Way Products, Inc. | Sustained release compositions for orally administered substances and methods |
WO2002036099A1 (en) | 2000-10-30 | 2002-05-10 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US6866866B1 (en) * | 2000-11-03 | 2005-03-15 | Andrx Labs, Llc | Controlled release metformin compositions |
US6790459B1 (en) | 2000-11-03 | 2004-09-14 | Andrx Labs, Llc | Methods for treating diabetes via administration of controlled release metformin |
US20060034922A1 (en) * | 2000-11-03 | 2006-02-16 | Andrx Labs, Llc | Controlled release metformin compositions |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US20030072731A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing starch or dextrin |
WO2003004009A1 (en) * | 2001-07-02 | 2003-01-16 | Geneva Pharmaceuticals, Inc. | Pharmaceutical composition |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
ITMI20012481A1 (it) | 2001-11-23 | 2003-05-23 | Univ Parma | Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale |
AU2003241537A1 (en) * | 2002-05-23 | 2003-12-12 | Andrx Corporation | Biguanide formulations |
US7718160B2 (en) * | 2002-07-02 | 2010-05-18 | The Board Of Regents Of The University Of Texas System | Radiolabeled compounds and liposomes and their method of making and using same |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US20080220074A1 (en) * | 2002-10-04 | 2008-09-11 | Elan Corporation Plc | Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same |
JP3811127B2 (ja) * | 2003-01-30 | 2006-08-16 | 株式会社東芝 | 情報記録装置及び情報記録方法 |
AR046410A1 (es) * | 2003-09-18 | 2005-12-07 | Cephalon Inc | Composiciones farmaceuticas para la liberacion modificada de modafinilo |
MXPA06003452A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente. |
US20050186273A1 (en) * | 2003-09-26 | 2005-08-25 | Si-Hong Yum | Controlled release dosage form including a banded engine |
JP5563731B2 (ja) * | 2003-09-26 | 2014-07-30 | アルザ・コーポレーシヨン | オピオイドおよび非オピオイド鎮痛薬の制御放出製剤 |
EP2184058B1 (en) | 2003-09-26 | 2012-02-08 | ALZA Corporation | Drug coating providing high drug loading and methods for providing the same |
ATE504288T1 (de) * | 2003-09-26 | 2011-04-15 | Alza Corp | Oros-push-stick für die kontrollierte abgabe von wirkstoffen |
KR20060109923A (ko) * | 2003-10-31 | 2006-10-23 | 알자 코포레이션 | 철분의 개선된 흡수를 위한 조성물 및 제형 |
US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
US6992359B2 (en) * | 2004-02-26 | 2006-01-31 | Grandis, Inc. | Spin transfer magnetic element with free layers having high perpendicular anisotropy and in-plane equilibrium magnetization |
US20110140217A1 (en) * | 2004-02-26 | 2011-06-16 | Grandis, Inc. | Spin transfer magnetic element with free layers having high perpendicular anisotropy and in-plane equilibrium magnetization |
SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20060121112A1 (en) * | 2004-12-08 | 2006-06-08 | Elan Corporation, Plc | Topiramate pharmaceutical composition |
US20070298098A1 (en) * | 2005-02-16 | 2007-12-27 | Elan Pharma International Limited | Controlled Release Compositions Comprising Levetiracetam |
WO2006110807A1 (en) * | 2005-04-12 | 2006-10-19 | Elan Pharma International Limited | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
CN101232868A (zh) * | 2005-04-19 | 2008-07-30 | 阿尔扎公司 | 曲马多和加巴喷丁的控释递药剂型 |
WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
AU2006261893A1 (en) * | 2005-06-23 | 2007-01-04 | Combinatorx, Incorporated | Improved dosage forms for movement disorder treatment |
WO2007011972A2 (en) * | 2005-07-19 | 2007-01-25 | Inverseon, Inc. | Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
US20070077309A1 (en) * | 2005-09-30 | 2007-04-05 | Wong Patrick S | Banded controlled release nanoparticle active agent formulation dosage forms and methods |
PL116330U1 (en) * | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
US9011930B2 (en) * | 2006-05-01 | 2015-04-21 | Zycal Bioceuticals Healthcare Company, Inc. | Nutritional supplement and use thereof |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US9101544B2 (en) * | 2006-08-30 | 2015-08-11 | Jagotec Ag | Controlled release nisoldipine compositions |
EP2063867A2 (en) * | 2006-12-22 | 2009-06-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
US20110031569A1 (en) * | 2009-08-10 | 2011-02-10 | Grandis, Inc. | Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements |
US8913350B2 (en) * | 2009-08-10 | 2014-12-16 | Grandis, Inc. | Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements |
US10446209B2 (en) | 2009-08-10 | 2019-10-15 | Samsung Semiconductor Inc. | Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements |
US9130151B2 (en) | 2010-01-11 | 2015-09-08 | Samsung Electronics Co., Ltd. | Method and system for providing magnetic tunneling junctions usable in spin transfer torque magnetic memories |
US8254162B2 (en) | 2010-01-11 | 2012-08-28 | Grandis, Inc. | Method and system for providing magnetic tunneling junctions usable in spin transfer torque magnetic memories |
US8546896B2 (en) | 2010-07-16 | 2013-10-01 | Grandis, Inc. | Magnetic tunneling junction elements having magnetic substructures(s) with a perpendicular anisotropy and memories using such magnetic elements |
WO2012024360A2 (en) * | 2010-08-18 | 2012-02-23 | Mcneil-Ppc, Inc. | Tablet sleeve for improved performance |
AU2011342893A1 (en) | 2010-12-13 | 2013-05-02 | Purdue Pharma L.P. | Controlled release dosage forms |
US8766383B2 (en) | 2011-07-07 | 2014-07-01 | Samsung Electronics Co., Ltd. | Method and system for providing a magnetic junction using half metallic ferromagnets |
US9580896B2 (en) | 2014-07-05 | 2017-02-28 | John David Hopkins | Apparatus and method for prolonged active agent in aqueous systems |
US9839212B2 (en) | 2015-04-16 | 2017-12-12 | Bio-Lab, Inc. | Multicomponent and multilayer compacted tablets |
US10583089B2 (en) | 2016-07-19 | 2020-03-10 | Johnson & Johnson Consumer Inc. | Tablets having discontinuous coated regions |
CN109689030A (zh) | 2016-07-19 | 2019-04-26 | 强生消费者公司 | 具有不连续涂覆区域的片剂 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4290426A (en) * | 1978-05-04 | 1981-09-22 | Alza Corporation | Dispenser for dispensing beneficial agent |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
US4824677A (en) * | 1986-12-18 | 1989-04-25 | The Unjohn Company | Grooved tablet for fractional dosing of sustained release medication |
US4792448A (en) * | 1987-06-11 | 1988-12-20 | Pfizer Inc. | Generic zero order controlled drug delivery system |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US4915950A (en) * | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5266332A (en) * | 1991-12-06 | 1993-11-30 | Alza Corporation | Method for administering anti-Parkinson drug |
US5629008A (en) | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
US5256440A (en) * | 1992-06-22 | 1993-10-26 | Merck & Co., Inc. | Process for producing a tablet core aperture |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
IT1265240B1 (it) * | 1993-11-30 | 1996-10-31 | Ekita Investments Nv | Compressa farmaceutica a rilascio controllato, di forma lenticolare |
US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
US5534263A (en) | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
IT1282650B1 (it) * | 1996-02-19 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
WO1999018938A1 (en) * | 1997-10-09 | 1999-04-22 | Perio Products Ltd. | Delayed total release gastrointestinal drug delivery system |
US6337091B1 (en) * | 1997-10-27 | 2002-01-08 | Temple University - Of The Commonwealth System Of Higher Education | Matrix for controlled delivery of highly soluble pharmaceutical agents |
-
1995
- 1995-02-24 US US08/394,074 patent/US5534263A/en not_active Expired - Lifetime
-
1996
- 1996-02-09 PT PT96907041T patent/PT810856E/pt unknown
- 1996-02-09 AU AU50226/96A patent/AU703681B2/en not_active Ceased
- 1996-02-09 EP EP96907041A patent/EP0810856B1/en not_active Expired - Lifetime
- 1996-02-09 ES ES96907041T patent/ES2155931T3/es not_active Expired - Lifetime
- 1996-02-09 NZ NZ303809A patent/NZ303809A/en unknown
- 1996-02-09 DK DK96907041T patent/DK0810856T3/da active
- 1996-02-09 CN CNB961920998A patent/CN1142771C/zh not_active Expired - Fee Related
- 1996-02-09 AT AT96907041T patent/ATE200421T1/de not_active IP Right Cessation
- 1996-02-09 KR KR1019970705869A patent/KR100465268B1/ko not_active IP Right Cessation
- 1996-02-09 JP JP52572496A patent/JP3955320B2/ja not_active Expired - Fee Related
- 1996-02-09 DE DE69612481T patent/DE69612481T2/de not_active Expired - Fee Related
- 1996-02-09 WO PCT/US1996/001848 patent/WO1996025922A2/en active IP Right Grant
- 1996-06-27 US US08/671,226 patent/US5667804A/en not_active Expired - Lifetime
-
1997
- 1997-08-21 NO NO19973840A patent/NO319216B1/no not_active IP Right Cessation
- 1997-08-22 FI FI973452A patent/FI973452A0/fi not_active Application Discontinuation
-
1998
- 1998-05-25 HK HK98104481A patent/HK1005794A1/xx not_active IP Right Cessation
- 1998-09-08 US US09/149,042 patent/US6020000A/en not_active Expired - Lifetime
-
2000
- 2000-08-31 US US09/652,655 patent/US6316028B1/en not_active Expired - Lifetime
-
2001
- 2001-04-12 GR GR20010400304T patent/GR3035743T3/el not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001519379A (ja) * | 1997-10-09 | 2001-10-23 | ペリオ、プロダクツ、リミテッド | 遅延性総放出胃腸薬物送達システム |
Also Published As
Publication number | Publication date |
---|---|
US6316028B1 (en) | 2001-11-13 |
NO319216B1 (no) | 2005-07-04 |
GR3035743T3 (en) | 2001-07-31 |
AU703681B2 (en) | 1999-04-01 |
KR19980702469A (ko) | 1998-07-15 |
NO973840D0 (no) | 1997-08-21 |
JP3955320B2 (ja) | 2007-08-08 |
US6020000A (en) | 2000-02-01 |
WO1996025922A3 (en) | 1996-10-03 |
FI973452A (fi) | 1997-08-22 |
NZ303809A (en) | 1999-04-29 |
NO973840L (no) | 1997-10-22 |
AU5022696A (en) | 1996-09-11 |
DE69612481D1 (de) | 2001-05-17 |
FI973452A0 (fi) | 1997-08-22 |
KR100465268B1 (ko) | 2005-04-06 |
ATE200421T1 (de) | 2001-04-15 |
US5667804A (en) | 1997-09-16 |
ES2155931T3 (es) | 2001-06-01 |
EP0810856B1 (en) | 2001-04-11 |
CN1175901A (zh) | 1998-03-11 |
CN1142771C (zh) | 2004-03-24 |
US5534263A (en) | 1996-07-09 |
HK1005794A1 (en) | 1999-01-29 |
WO1996025922A2 (en) | 1996-08-29 |
EP0810856A2 (en) | 1997-12-10 |
MX9706484A (es) | 1997-11-29 |
DK0810856T3 (da) | 2001-05-07 |
PT810856E (pt) | 2001-09-28 |
DE69612481T2 (de) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3955320B2 (ja) | バンド付き持続放出活性剤投与形 | |
US4721613A (en) | Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use | |
US4863744A (en) | Intestine drug delivery | |
US4434153A (en) | Drug delivery system comprising a reservoir containing a plurality of tiny pills | |
US6120803A (en) | Prolonged release active agent dosage form adapted for gastric retention | |
US4851232A (en) | Drug delivery system with means for obtaining desirable in vivo release rate pattern | |
US6602521B1 (en) | Multiplex drug delivery system suitable for oral administration | |
US4649043A (en) | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract | |
US6365183B1 (en) | Method of fabricating a banded prolonged release active agent dosage form | |
JP2002533380A (ja) | 多孔性粒子を含む剤形 | |
WO1999051209A1 (en) | Press coated, pulsatile drug delivery system suitable for oral administration | |
US4851231A (en) | System for delivering drug in selected environment of use | |
US4659558A (en) | Oral delivery system comprising a plurality of tiny pills for delivering drug in the stomach and intestine | |
JP2003306428A (ja) | 服用性を改善した硬カプセル剤 | |
MXPA97006484A (en) | Form of dose of active agent of prolonged release with ban | |
EP1413296A1 (en) | Method of fabricating a banded prolonged release active agent dosage form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060905 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061205 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070403 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070502 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |